JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer
Sarah Alexandrou(Garvan Institute of Medical Research), C. Elizabeth Caldon(Garvan Institute of Medical Research)
Cited by 1
Related Papers
Cell cycle control in breast cancer cells
|Journal of Cellular Biochemistry|2005|234